1. Ekizoglu, Seda, Seven, Didem, Ulutin, Turgut, Guliyev, Jalal, Buyru, Nur. 2018. Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma. In BMC cancer, 18, 477. doi:10.1186/s12885-018-4381-y. https://pubmed.ncbi.nlm.nih.gov/29703252/
2. Serrano León, Alejandra, Amir Shaghaghi, Mandana, Yurkova, Natalia, El-Gabalawy, Hani, Eck, Peter. 2014. Single-nucleotide polymorphisms in SLC22A23 are associated with ulcerative colitis in a Canadian white cohort. In The American journal of clinical nutrition, 100, 289-94. doi:10.3945/ajcn.113.080549. https://pubmed.ncbi.nlm.nih.gov/24740203/
3. Uchimura, Yasuhiro, Hino, Kodai, Hattori, Kosuke, Mashimo, Tomoji, Udagawa, Jun. 2024. Knockout of the orphan membrane transporter Slc22a23 leads to a lean and hyperactive phenotype with a small hippocampal volume. In PloS one, 19, e0309461. doi:10.1371/journal.pone.0309461. https://pubmed.ncbi.nlm.nih.gov/39197039/
4. Toba-Oluboka, Temi, Tibbo, Philip G, Dempster, Kara, Alda, Martin. 2022. Genetic factors contribute to medication-induced QT prolongation: A review. In Psychiatry research, 317, 114891. doi:10.1016/j.psychres.2022.114891. https://pubmed.ncbi.nlm.nih.gov/36257205/
5. Aberg, K, Adkins, D E, Liu, Y, Sullivan, P F, van den Oord, E J C G. 2010. Genome-wide association study of antipsychotic-induced QTc interval prolongation. In The pharmacogenomics journal, 12, 165-72. doi:10.1038/tpj.2010.76. https://pubmed.ncbi.nlm.nih.gov/20921969/
6. Yotova, Iveta, Hsu, Emily, Do, Catherine, Wenzl, Rene, Tycko, Benjamin. 2017. Epigenetic Alterations Affecting Transcription Factors and Signaling Pathways in Stromal Cells of Endometriosis. In PloS one, 12, e0170859. doi:10.1371/journal.pone.0170859. https://pubmed.ncbi.nlm.nih.gov/28125717/